Global Stem Cell and Gene Therapy Biological Testing Market, By Product Type (Cell Therapy and Gene Therapy), End Users (Hospitals, Wound Care Centres, Cancer Care Centres, Ambulatory Surgical Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Stem Cell and Gene Therapy Biological Testing Market
Data Bridge Market Research analyses that the stem cell and gene therapy biological testing market will exhibit a CAGR of around 14.87% for the forecast period of 2021-2028. Rising approvals of GMP-certified facilities to manufacture stem cells, rising stem cell research activities and increasing public and private expenditure for the development of healthcare infrastructure especially in emerging economies are the major factors attributable to the growth of stem cell and gene therapy biological testing market. This signifies that the stem cell and gene therapy biological testing market value, which was USD 1,497.03 million in 2020, will rocket up to USD 4,538.22 million by the year 2028.
Stem cell therapy is gaining proficiency in the healthcare sector. Stem cell therapy is used to prevent a disease or any condition by using stem cells. However, gene therapy incorporated the use of genes to treat any condition or prevent diseases. In gene therapy, the genes of the patient are modified to cure any prevailing disease.
Upsurge in the demand for CAR T-cell therapy products globally is one of the major factors inducing growth in the demand for stem cell and gene therapy biological testing. Rising prevalence of chronic diseases such as cancer, diabetes, blood diseases, and other immunity related diseases will further generate lucrative and remunerative growth opportunities for the stem cell and gene therapy biological testing market. Growing awareness among patients coupled with favourable reimbursement policies in matured markets will also act as important market growth determinants.
However, high costs associated with stem cell therapy will derail the stem cell and gene therapy biological testing market growth rate. Also, emphasis on high-quality products at low costs will slow down the market growth rate. Availability of alternative treatment options will also create hindrances.
This stem cell and gene therapy biological testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on stem cell and gene therapy biological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Stem Cell and Gene Therapy Biological Testing Market Scope and Market Size
The stem cell and gene therapy biological testing market is segmented on the basis of product type and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
By product type, the global stem cell and gene therapy biological testing market is segmented into cell therapy and gene therapy.
- On the end users, the stem cell and gene therapy biological testing market is segmented into hospitals, wound care centres, cancer care centres, ambulatory surgical centres and others.
Stem Cell and Gene Therapy Biological Testing Market Country Level Analysis
The stem cell and gene therapy biological testing market is analysed and market size insights and trends are provided by product type and end users as referenced above.
The countries covered in the stem cell and gene therapy biological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the stem cell and gene therapy biological testing market owing to the rising expenditure for research and development activities for the introduction safe and effective stem cell and gene therapy products coupled with favourable reimbursement scenario in the region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the rising prevalence of cancer and other chronic diseases and improving healthcare infrastructure.
The country section of the stem cell and gene therapy biological testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The stem cell and gene therapy biological testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell and gene therapy biological testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Stem Cell and Gene Therapy Biological Testing Market Share Analysis
The stem cell and gene therapy biological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to stem cell and gene therapy biological testing market.
The major players covered in the stem cell and gene therapy biological testing market report are MEDIPOST, Smith & Nephew, ANTEROGEN.CO.,LTD., PHARMICELL Co., Ltd, JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., Gilead Sciences, Inc., Dendreon Pharmaceuticals LLC., Organogenesis Inc., Osiris., STEMCELL Technologies Inc., Athersys, Inc., Cryo-Cell, Astellas Pharma Inc., Cellular Engineering Technologies., Takara Bio Inc., LifeCell International Pvt. Ltd., Thermo Fisher Scientific Inc., AbbVie Inc. and BrainStorm Cell Limited. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-